View more on these topics

Nucleus eyes ‘hybrid fee’ in pricing review

Neilson-Barry-2010-700x450.jpg

Nucleus is eyeing a “hybrid fee” model to share costs between advisers and clients in a review of its pricing.

The platform is exploring how the firm would offer a hybrid pricing model, where both advisers and clients will pay a fee for the platform, with the latter paying a lesser amount.

Nucleus business development director Barry Neilson argues such models will become “more common” among platforms.

He says: “We are looking at a hybrid model carefully and how we would offer that and what that would mean for some of the firms that use Nucleus as an option.”

The platform is also looking to cut its fees next year, and while it has not decided by how much, Neilson says the firm will review its standard pricing models in the next two months with a view to changing them next year.

Currently Nucleus charges an annual 0.35 per cent on a tiered basis for assets up to £500,000, falling to 0.25 per cent when clients hold more than £1m and 0.15 on the balance thereafter.

Neilson says: “We are reviewing our pricing to ensure our clients benefit by way of fee reductions from the scale and sustainable profitability that Nucleus can now demonstrate whilst ensuring we can also continue to increase the sums we invest in our functionality and service.

“We are very sceptical about the ability of some of the platforms to sustain their pricing models and we are always trying to come up with a responsible pricing model to stay in the business in the next 10 years.”

Recommended

David-Ferguson-Nucleus-500x320.jpg

Sanlam to offload £3.6m Nucleus shares

Sanlam is selling more than £3.6m worth of Nucleus shares, Money Marketing can reveal. In a note to shareholders, seen by Money Marketing, the platform reveals Sanlam wants to offer 109,765 Nucleus B shares at £33 each. The shares are only being offered to Nucleus users. Sanlam purchased the shares earlier this year as payment […]

David-Ferguson-Nucleus-2013-700x450.jpg
1

Nucleus pulls back on IPO plans

Nucleus has delayed plans to explore flotation after advisers reacted negatively to the proposal. Chief executive David Ferguson told Money Marketing in February that the terms of its ownership required the adviser-owned firm to explore a float this year. However, chief financial officer Doug Heron now says the plans have been shelved. He says: “Our […]

Patient - thumbnail

Company sick pay – new findings

Research by insurer LV= suggests that some 11 million employees in the UK have no company-paid sick leave entitlement. So if an employee from within the above grouping cannot work through illness or injury for any period of time, their only income would likely be that provided by state benefits alone.

Newsletter

News and expert analysis straight to your inbox

Sign up

Comments

    Leave a comment